作者
David C Henderson, Enrico Cagliero, Paul M Copeland, Christina P Borba, Anne Eden Evins, Doug Hayden, Mary T Weber, Ellen J Anderson, David B Allison, Tara B Daley, David Schoenfeld, Donald C Goff
发表日期
2005/1/1
期刊
Archives of general psychiatry
卷号
62
期号
1
页码范围
19-28
出版商
American Medical Association
简介
Background
While the incidence of new-onset diabetes mellitus may be increasing in patients with schizophrenia treated with certain atypical antipsychotic agents, it remains unclear whether atypical agents are directly affecting glucose metabolism or simply increasing known risk factors for diabetes.
Objective
To study the 2 drugs most clearly implicated (clozapine and olanzapine) and risperidone using a frequently sampled intravenous glucose tolerance test.
Design
A cross-sectional design in stable, treated patients with schizophrenia evaluated using a frequently sampled intravenous glucose tolerance test and the Bergman minimal model analysis.
Setting
Subjects were recruited from an urban community mental health clinic and were studied at a general clinical research center.
Patients
Fifty subjects signed informed consent and 41 underwent the frequently sampled intravenous glucose tolerance test. Thirty-six …
引用总数
2004200520062007200820092010201120122013201420152016201720182019202020212022202320242195839585027343342251721141219108641